Biogen Bets on Experimental Alzheimer’s Therapy Despite Trial Questions
Highlights Biogen plans to move its experimental Alzheimer’s treatment diranersen into late-stage clinical trials despite mixed mid-stage results. The drug failed to demonstrate stronger outcomes at higher doses, raising questions…